SAR125844
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for SAR125844, covering 2016-02-17 to 2016-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors [Phase 1]